PCAR vs RELX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
PACCAR exhibits strong fundamental health with a Piotroski F-Score of 7/9 and robust liquidity ratios, yet it faces a severe valuation disconnect. The current price of $127.20 trades at a significant premium to both the Graham Number ($61.0) and the growth-based Intrinsic Value ($31.57). While the balance sheet is a fortress, the company is currently grappling with sharp declines in YoY revenue (-13.7%) and earnings (-35.9%), coupled with bearish insider activity from the CEO and CFO.
RELX exhibits a stable financial foundation with a Piotroski F-Score of 6/9, though it faces short-term liquidity pressures. While the Graham Number is negligible due to an asset-light business model (P/B of 82.9), the stock is trading at a significant discount to its intrinsic value of $44.84 and analyst targets of $52.45. Exceptional ROE (70.51%) and strong earnings growth (17%) suggest high operational efficiency despite stagnant revenue growth. The current price represents a potential value entry following a severe 31.7% one-year correction.
Compare Another Pair
Related Comparisons
PCAR vs RELX: Head-to-Head Comparison
This page compares PACCAR Inc (PCAR) and RELX PLC (RELX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.